Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease

Cysteinyl leukotrienes (CysLTs: leukotrienes C4, D4, and E4) have long been implicated in the pathogenesis of asthma and several allergic diseases. LTE4 has been identified as a major metabolite of LTC4, and urinary LTE4 (U-LTE4) is considered as the most reliable analytic parameter for monitoring t...

Full description

Bibliographic Details
Main Authors: Masami Taniguchi, Noritaka Higashi, Emiko Ono, Haruhisa Mita, Kazuo Akiyama
Format: Article
Language:English
Published: Elsevier 2008-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015307942
_version_ 1818928888000020480
author Masami Taniguchi
Noritaka Higashi
Emiko Ono
Haruhisa Mita
Kazuo Akiyama
author_facet Masami Taniguchi
Noritaka Higashi
Emiko Ono
Haruhisa Mita
Kazuo Akiyama
author_sort Masami Taniguchi
collection DOAJ
description Cysteinyl leukotrienes (CysLTs: leukotrienes C4, D4, and E4) have long been implicated in the pathogenesis of asthma and several allergic diseases. LTE4 has been identified as a major metabolite of LTC4, and urinary LTE4 (U-LTE4) is considered as the most reliable analytic parameter for monitoring the endogenous synthesis of CysLTs. From recent studies on the U-LTE4 associated with adult stable asthma we identified four factors for hyperleukotrieneuria, namely, aspirin intolerance, eosinophilic nasal polyposis (ENP), vasculitis, and severe asthma. In ENP, there is prominent infiltration of eosinophils in the sinus and polyp tissues, which is linked to adult asthma and aspirin sensitivity, and ENP is the most important factor for the overproduction of CysLTs in asthmatics. We also demonstrated that anaphylaxis and eosinophilic pneumonia (EP) are associated with a marked increase in the U-LTE4 concentration. Under these disease conditions, U-LTE4 may be one of the candidate biomarkers. Moreover, the changes in U-LTE4 concentrations may provide valuable information concerning therapeutic targets.
first_indexed 2024-12-20T03:36:03Z
format Article
id doaj.art-78a2ce7517ff4078be7004c725a47c32
institution Directory Open Access Journal
issn 1323-8930
language English
last_indexed 2024-12-20T03:36:03Z
publishDate 2008-01-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj.art-78a2ce7517ff4078be7004c725a47c322022-12-21T19:54:53ZengElsevierAllergology International1323-89302008-01-0157431332010.2332/allergolint.08-RAI-0040Hyperleukotrieneuria in Patients with Allergic and Inflammatory DiseaseMasami Taniguchi0Noritaka Higashi1Emiko Ono2Haruhisa Mita3Kazuo Akiyama4Clinical Research Center, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.Clinical Research Center, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.Clinical Research Center, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.Clinical Research Center, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.Clinical Research Center, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.Cysteinyl leukotrienes (CysLTs: leukotrienes C4, D4, and E4) have long been implicated in the pathogenesis of asthma and several allergic diseases. LTE4 has been identified as a major metabolite of LTC4, and urinary LTE4 (U-LTE4) is considered as the most reliable analytic parameter for monitoring the endogenous synthesis of CysLTs. From recent studies on the U-LTE4 associated with adult stable asthma we identified four factors for hyperleukotrieneuria, namely, aspirin intolerance, eosinophilic nasal polyposis (ENP), vasculitis, and severe asthma. In ENP, there is prominent infiltration of eosinophils in the sinus and polyp tissues, which is linked to adult asthma and aspirin sensitivity, and ENP is the most important factor for the overproduction of CysLTs in asthmatics. We also demonstrated that anaphylaxis and eosinophilic pneumonia (EP) are associated with a marked increase in the U-LTE4 concentration. Under these disease conditions, U-LTE4 may be one of the candidate biomarkers. Moreover, the changes in U-LTE4 concentrations may provide valuable information concerning therapeutic targets.http://www.sciencedirect.com/science/article/pii/S1323893015307942anaphylaxisaspirin-intolerant asthma (AIA)Churg-Strauss syndrome (CSS)cysteinyl leukotrienes (CysLTs)nasal polyp
spellingShingle Masami Taniguchi
Noritaka Higashi
Emiko Ono
Haruhisa Mita
Kazuo Akiyama
Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
Allergology International
anaphylaxis
aspirin-intolerant asthma (AIA)
Churg-Strauss syndrome (CSS)
cysteinyl leukotrienes (CysLTs)
nasal polyp
title Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
title_full Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
title_fullStr Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
title_full_unstemmed Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
title_short Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease
title_sort hyperleukotrieneuria in patients with allergic and inflammatory disease
topic anaphylaxis
aspirin-intolerant asthma (AIA)
Churg-Strauss syndrome (CSS)
cysteinyl leukotrienes (CysLTs)
nasal polyp
url http://www.sciencedirect.com/science/article/pii/S1323893015307942
work_keys_str_mv AT masamitaniguchi hyperleukotrieneuriainpatientswithallergicandinflammatorydisease
AT noritakahigashi hyperleukotrieneuriainpatientswithallergicandinflammatorydisease
AT emikoono hyperleukotrieneuriainpatientswithallergicandinflammatorydisease
AT haruhisamita hyperleukotrieneuriainpatientswithallergicandinflammatorydisease
AT kazuoakiyama hyperleukotrieneuriainpatientswithallergicandinflammatorydisease